Pfizer’s CEO said the company is currently focused on developing a COVID-19 vaccine that offers protection for at least one year in anticipation that longer lasting efficacy will encourage more people to stay up to date with vaccine recommendations.
Read the full post on Becker's Hospital Review - Healthcare News
